Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2022

Recurrent or metastatic nasopharyngeal cancer

Developing treatment for recurrent or metastatic nasopharyngeal cancer

Date

04 Dec 2022

Session

Recurrent or metastatic nasopharyngeal cancer

Topics

Multi-Disciplinary and Multi-Professional Cancer Care;  Immunotherapy;  Radiation Oncology

Tumour Site

Head and Neck Cancers

Presenters

Eduardo Netto

Authors

E. Netto

Author affiliations

  • Radiation Oncology, Instituto Portuguès de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO Lisboa), 1099-023 - Lisbon/PT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Q&A and discussion

Presenter: Sheng-Po Hao

Session: Recurrent or metastatic nasopharyngeal cancer

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.